查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564084

全球全玻片成像市場

Whole Slide Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球全玻片成像市場預計將達到 29 億美元

2023年全球全玻片成像市場估計為8.907億美元，預計到2030年將達到29億美元，2023年至2030年複合年成長率為18.3%。全幻燈片成像硬體是本報告分析的細分市場之一，預計複合年成長率為 18.9%，到分析期結束時將達到 15 億美元。在分析期間，整個幻燈片成像軟體領域的複合年成長率預計為 17.8%。

美國市場預估為2.415億美元，中國預期複合年成長率為16.9%

到 2023 年，美國整體幻燈片成像市場預計將達到 2.415 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到4.246億美元，2023-2030年分析期間複合年成長率為16.9%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 16.5% 和 15.6%。在歐洲，德國的複合年成長率預計約為 13.0%。

全球幻燈片成像市場 - 主要趨勢和促進因素總結

為什麼全玻片成像會改變病理學和診斷業務？

全切片成像 (WSI) 透過實現整個組織切片的數位化以及高解析度檢查、儲存和共用病理切片，正在徹底改變病理學和診斷領域。該技術促進遠距會診、數位存檔和人工智慧主導的分析，以提高腫瘤學、血液學和感染疾病的診斷準確性和效率。由於改進診斷工作流程、遠端病理學和人工智慧整合的需求，數位病理學的日益普及正在推動對 WSI 系統的需求。隨著個人化醫療的興起以及對準確和可重複診斷資料的需求，WSI 正在成為現代醫療保健的重要工具。

科技進步如何增強整個幻燈片成像系統？

成像硬體、資料管理和人工智慧的技術進步大大提高了全切片成像系統的功能和應用。具有更高解析度和焦深的更快掃描儀的發展使得組織形態和病理學的可視化更加準確和詳細。資料壓縮和雲端儲存解決方案的創新正在改善大型影像資料集的處理、儲存和搜尋，促進病理實驗室的無縫數位工作流程。此外，人工智慧和機器學習演算法的整合可以實現自動影像分析、模式識別和預測診斷，減少病理學家的工作量並提高診斷準確性。這些進步正在推動 WSI 在臨床診斷、研究和教育中的採用。

整個幻燈片成像市場面臨哪些挑戰與機會？

整個幻燈片成像市場面臨多項挑戰，包括WSI系統的高初始成本、資料管理的複雜性以及數位病理平台之間標準化和互通性的需求。此外，監管障礙和臨床使用數位病理系統檢驗的需求可能會減緩採用速度。但這些挑戰也帶來了成長和創新的機會。開發具有成本效益且擴充性的WSI 解決方案，提供高品質的影像、與現有實驗室基礎設施的輕鬆整合以及強大的資料管理功能，將推動臨床和研究環境的採用。對第二意見和專家知識的需求正在推動對遠端病理學和遠距離診斷的需求，為支援無縫數位諮詢和協作的 WSI 系統創造新的成長機會。此外，對人工智慧主導的診斷和精準醫療的日益關注正在推動對先進 WSI 解決方案的需求，這些解決方案可為臨床決策提供可靠且可重複的資料。

整個幻燈片成像市場成長的驅動力是什麼？

整個幻燈片成像市場的成長也受到多種因素的推動，例如數位病理學的日益普及、對遠端病理診斷和遠距離診斷的需求不斷成長，以及成像硬體、資料管理和人工智慧主導分析的技術進步。應用。病理診斷中對提高診斷準確性、效率和協作的需求正在顯著推動臨床和研究環境中對 WSI 系統的市場需求。高解析度成像、雲端儲存和基於人工智慧的分析方面的創新正在提高 WSI 系統的功能和擴充性，使其對醫院、研究機構和診斷實驗室更具吸引力。此外，個人化醫療的擴展和對數位醫療轉型的日益重視也推動了市場成長，因為相關人員尋求先進的數位病理工具來改善診斷工作流程和病患治療結果。

受訪企業範例（47家知名企業）

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP15632

Global Whole Slide Imaging Market to Reach US$2.9 Billion by 2030

The global market for Whole Slide Imaging estimated at US$890.7 Million in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Whole Slide Imaging Hardware, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Whole Slide Imaging Software segment is estimated at 17.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.5 Million While China is Forecast to Grow at 16.9% CAGR

The Whole Slide Imaging market in the U.S. is estimated at US$241.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$424.6 Million by the year 2030 trailing a CAGR of 16.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Whole Slide Imaging Market - Key Trends & Drivers Summarized

Why Is Whole Slide Imaging Transforming Pathology and Diagnostic Practices?

Whole Slide Imaging (WSI) is revolutionizing the field of pathology and diagnostic practices by enabling the digitization of entire histological slides, allowing for high-resolution examination, storage, and sharing of pathology slides. This technology facilitates remote consultations, digital archiving, and AI-driven analysis, enhancing the accuracy and efficiency of diagnostics in oncology, hematology, and infectious diseases. The increasing adoption of digital pathology, driven by the need for improved diagnostic workflows, telepathology, and the integration of artificial intelligence, is propelling the demand for WSI systems. With the rise of personalized medicine and the need for precise and reproducible diagnostic data, WSI is becoming a crucial tool in modern healthcare.

How Are Technological Advancements Enhancing Whole Slide Imaging Systems?

Technological advancements in imaging hardware, data management, and artificial intelligence are significantly enhancing the capabilities and applications of whole slide imaging systems. The development of high-speed scanners with higher resolution and depth of focus is enabling more accurate and detailed visualization of tissue morphology and pathology. Innovations in data compression and cloud storage solutions are improving the handling, storage, and retrieval of large image datasets, facilitating seamless digital workflows in pathology labs. Additionally, the integration of AI and machine learning algorithms is enabling automated image analysis, pattern recognition, and predictive diagnostics, reducing the workload on pathologists and increasing diagnostic accuracy. These advancements are driving the adoption of WSI in clinical diagnostics, research, and education.

What Are the Challenges and Opportunities in the Whole Slide Imaging Market?

The whole slide imaging market faces several challenges, including high initial costs of WSI systems, data management complexities, and the need for standardization and interoperability across digital pathology platforms. Additionally, regulatory hurdles and the need for validation of digital pathology systems for clinical use can slow down adoption. However, these challenges also present opportunities for growth and innovation. The development of cost-effective and scalable WSI solutions that offer high-quality imaging, easy integration with existing lab infrastructure, and robust data management capabilities can help drive adoption in both clinical and research settings. The increasing demand for telepathology and remote diagnostics, driven by the need for second opinions and specialized expertise, is creating new growth opportunities for WSI systems that support seamless digital consultation and collaboration. Moreover, the rising focus on AI-driven diagnostics and precision medicine is driving the need for advanced WSI solutions that provide reliable and reproducible data for clinical decision-making.

What Is Driving the Growth of the Whole Slide Imaging Market?

The growth in the Whole Slide Imaging market is driven by several factors, including the increasing adoption of digital pathology, rising demand for telepathology and remote diagnostics, and technological advancements in imaging hardware, data management, and AI-driven analysis. The need for improved diagnostic accuracy, efficiency, and collaboration in pathology is significantly boosting market demand for WSI systems in clinical and research settings. Technological innovations in high-resolution imaging, cloud storage, and AI-based analytics are enhancing the capabilities and scalability of WSI systems, making them more attractive to hospitals, research institutes, and diagnostic labs. The expansion of personalized medicine and the growing emphasis on digital healthcare transformation are also driving market growth as stakeholders seek advanced digital pathology tools to enhance diagnostic workflows and patient outcomes.

Select Competitors (Total 47 Featured) -

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Whole Slide Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Digital Pathology Solutions Drives Whole Slide Imaging Market
    • Technological Advancements in Imaging and Analysis Propel Market Growth
    • Increased Adoption in Clinical Diagnostics Enhances Whole Slide Imaging Utilization
    • Growth in Cancer Research Necessitates Efficient Whole Slide Imaging Solutions
    • Integration of AI and Machine Learning in Image Analysis Expands Capabilities
    • Global Expansion of Telepathology Services Amplifies Whole Slide Imaging Demand
    • Regulatory and Compliance Requirements Influence Whole Slide Imaging Adoption
    • Developments in High-Throughput Scanning Technologies Boost Market Efficiency
    • Rising Healthcare Expenditure Worldwide Sustains Investment in Digital Imaging
    • Technological Convergence in Healthcare IT Systems Promotes Interoperability
    • Data Management and Storage Challenges Drive Solutions in Digital Pathology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Slide Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Telepathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Telepathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cytopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Cytopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hematopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Hematopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • JAPAN
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CHINA
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • EUROPE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • FRANCE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • GERMANY
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • UNITED KINGDOM
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030

IV. COMPETITION